ANNA PRICE: Open Payments
NPI 1902553613 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$526 in 24 payments from 9 companies in 2025. Trend: 2023 $668 · 2024 $390 · 2025 $526
Food & beverage: $526
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $153 |
| Teva Pharmaceuticals USA, Inc. | 9 | $146 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| Dexcom, Inc. | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Globus Medical, Inc. | 1 | $18 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: AUSTEDO XR, Ozempic, REXULTI, Dexcom G6 Transmitter, VOQUEZNA, Senza, ELIQUIS, XIFAXAN.
Industry payments across LA — which companies pay providers there.
